logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
Ceased 1
  • Dr Graham Michael Wynne
    Born in March 1971
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2023-01-19 ~ 2023-07-18
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

RHINO THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
2,222 GBP2025-03-31
3,790 GBP2024-03-31
Debtors
1,233,310 GBP2025-03-31
734,876 GBP2024-03-31
Cash at bank and in hand
28,943 GBP2025-03-31
233,454 GBP2024-03-31
Current Assets
1,262,253 GBP2025-03-31
968,330 GBP2024-03-31
Creditors
Current
606,962 GBP2025-03-31
762,609 GBP2024-03-31
Net Current Assets/Liabilities
655,291 GBP2025-03-31
205,721 GBP2024-03-31
Total Assets Less Current Liabilities
657,513 GBP2025-03-31
209,511 GBP2024-03-31
Net Assets/Liabilities
656,957 GBP2025-03-31
208,563 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
Retained earnings (accumulated losses)
656,857 GBP2025-03-31
208,463 GBP2024-03-31
Equity
656,957 GBP2025-03-31
208,563 GBP2024-03-31
Average Number of Employees
22024-04-01 ~ 2025-03-31
22023-01-19 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
4,705 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,483 GBP2025-03-31
915 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
1,568 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
2,222 GBP2025-03-31
3,790 GBP2024-03-31
Amounts Owed by Group Undertakings
Current
730,526 GBP2025-03-31
492,309 GBP2024-03-31
Other Debtors
Current, Amounts falling due within one year
502,784 GBP2025-03-31
Amounts falling due within one year, Current
242,567 GBP2024-03-31
Debtors
Current, Amounts falling due within one year
1,233,310 GBP2025-03-31
Amounts falling due within one year, Current
734,876 GBP2024-03-31
Trade Creditors/Trade Payables
Current
382,119 GBP2025-03-31
671,560 GBP2024-03-31
Corporation Tax Payable
Current
146,739 GBP2025-03-31
71,658 GBP2024-03-31
Other Taxation & Social Security Payable
Current
1,558 GBP2025-03-31
1,292 GBP2024-03-31
Other Creditors
Current
961 GBP2025-03-31
1,734 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
75,585 GBP2025-03-31
16,365 GBP2024-03-31

  • RHINO THERAPEUTICS LIMITED
    Info
    Registered number 14604755
    icon of addressFourth Floor St James House, St James' Square, Cheltenham GL50 3PR
    PRIVATE LIMITED COMPANY incorporated on 2023-01-19 (3 years). The company status is Active.
    The last date of confirmation statement was made at 2025-01-18
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.